Riehen, Switzerland

Iker Navarro

This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignee: Noorik Biopharmaceuticals Ag. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Iker Navarro. Retrieved from https://idiyas.com/inventor/iker-navarro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.2

ph-index = 1


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Iker Navarro: Innovator in Biopharmaceuticals

Introduction

Iker Navarro is a prominent inventor based in Riehen, Switzerland. With three patents to his name, Navarro has made significant contributions to the field of biopharmaceuticals, particularly in the treatment of serious health conditions.

Latest Patents

Navarro's latest patents include innovative methods and formulations aimed at addressing portal hypertension and cirrhosis. The first patent focuses on the treatment and prevention of portal hypertension, providing new avenues for managing this serious condition. His second patent involves the use of Ambrisentan, specifically for the treatment of acute renal failure. This formulation is designed to combat renal vasoconstriction, showcasing Navarro's commitment to improving patient outcomes in critical health scenarios.

Career Highlights

Navarro currently works at Noorik Biopharmaceuticals AG, where he applies his expertise in the development of novel therapeutics. His work at Noorik underscores his dedication to translating scientific research into practical medical solutions that have the potential to benefit countless patients worldwide.

Collaborations

Collaboration is vital in the process of innovation, and Navarro has teamed up with esteemed colleagues, including Satish Chandra Khanna. Together, they contribute to the advancement of biopharmaceutical research, enhancing the efficacy and safety of treatments available today.

Conclusion

Iker Navarro exemplifies the spirit of innovation in the biopharmaceutical sector. With his remarkable patents and collaborative efforts, he continues to drive advancements that hold promise for effective medical therapies. His work is not only valuable to the medical community but also pivotal in enhancing the quality of life for patients facing severe health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…